[
{
"old_id":"1",
"old_nametree":"Authors and legal information",
"old_numtree":"1.0.0.0",
"old_htmlpage":"ENAS5092_1.0.0.0",
"new_id":"1",
"new_nametree":"Authors and legal information",
"new_numtree":"1.0.0.0",
"new_htmlpage":"ENAS5092_1.0.0.0"
},
{
"old_id":"2",
"old_nametree":"Diagnosis and pathology",
"old_numtree":"2.0.0.0",
"old_htmlpage":"ENAS5092_2.0.0.0",
"new_id":"2",
"new_nametree":"Diagnosis and pathology",
"new_numtree":"2.0.0.0",
"new_htmlpage":"ENAS5092_2.0.0.0"
},
{
"old_id":"3",
"old_nametree":"Staging and risk assessment",
"old_numtree":"3.0.0.0",
"old_htmlpage":"null",
"new_id":"3",
"new_nametree":"Staging and risk assessment",
"new_numtree":"3.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"4",
"old_nametree":"Overview",
"old_numtree":"3.1.0.0",
"old_htmlpage":"ENAS5092_3.1.0.0",
"new_id":"4",
"new_nametree":"Overview",
"new_numtree":"3.1.0.0",
"new_htmlpage":"ENAS5092_3.1.0.0"
},
{
"old_id":"5",
"old_nametree":"TNM staging",
"old_numtree":"3.2.0.0",
"old_htmlpage":"ENAS5092_3.2.0.0",
"new_id":"5",
"new_nametree":"TNM staging",
"new_numtree":"3.2.0.0",
"new_htmlpage":"ENAS5092_3.2.0.0"
},
{
"old_id":"6",
"old_nametree":"Risk groups for localised prostate CA",
"old_numtree":"3.3.0.0",
"old_htmlpage":"ENAS5092_3.3.0.0",
"new_id":"6",
"new_nametree":"Risk groups for localised prostate CA",
"new_numtree":"3.3.0.0",
"new_htmlpage":"ENAS5092_3.3.0.0"
},
{
"old_id":"7",
"old_nametree":"Treatment",
"old_numtree":"4.0.0.0",
"old_htmlpage":"null",
"new_id":"7",
"new_nametree":"Treatment",
"new_numtree":"4.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"8",
"old_nametree":"Therapeutic strategies",
"old_numtree":"4.1.0.0",
"old_htmlpage":"ENAS5092_4.1.0.0",
"new_id":"8",
"new_nametree":"Therapeutic strategies",
"new_numtree":"4.1.0.0",
"new_htmlpage":"ENAS5092_4.1.0.0"
},
{
"old_id":"9",
"old_nametree":"Diagnosis and staging",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS5092_2017032736",
"new_id":"9",
"new_nametree":"Diagnosis and staging",
"new_numtree":"4.2.0.0",
"new_htmlpage":"ENAS5092_2017032736"
},
{
"old_id":"10",
"old_nametree":"Management of local/ locoregional disease",
"old_numtree":"4.3.0.0",
"old_htmlpage":"null",
"new_id":"10",
"new_nametree":"Management of local/ locoregional disease",
"new_numtree":"4.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"11",
"old_nametree":"Overview",
"old_numtree":"4.3.1.0",
"old_htmlpage":"ENAS5092_4.2.1.0",
"new_id":"11",
"new_nametree":"Overview",
"new_numtree":"4.3.1.0",
"new_htmlpage":"ENAS5092_4.2.1.0"
},
{
"old_id":"12",
"old_nametree":"Hormone treatment",
"old_numtree":"4.3.2.0",
"old_htmlpage":"ENAS5092_4.2.2.0",
"new_id":"12",
"new_nametree":"Hormone treatment",
"new_numtree":"4.3.2.0",
"new_htmlpage":"ENAS5092_4.2.2.0"
},
{
"old_id":"13",
"old_nametree":"Post-operative radiotherapy",
"old_numtree":"4.3.3.0",
"old_htmlpage":"ENAS5092_4.2.3.0",
"new_id":"13",
"new_nametree":"Postoperative radiotherapy",
"new_numtree":"4.3.3.0",
"new_htmlpage":"ENAS5092_4.2.3.0"
},
{
"old_id":"14",
"old_nametree":"Treatment of relapse",
"old_numtree":"4.3.4.0",
"old_htmlpage":"ENAS5092_4.2.4.0",
"new_id":"14",
"new_nametree":"Treatment of relapse",
"new_numtree":"4.3.4.0",
"new_htmlpage":"ENAS5092_4.2.4.0"
},
{
"old_id":"15",
"old_nametree":"Treatment of localised disease",
"old_numtree":"4.3.5.0",
"old_htmlpage":"ENAS5092_2017032738",
"new_id":"15",
"new_nametree":"Treatment of localised disease",
"new_numtree":"4.3.5.0",
"new_htmlpage":"ENAS5092_2017032738"
},
{
"old_id":"16",
"old_nametree":"Rx.of localised and locally advanced disease",
"old_numtree":"4.3.6.0",
"old_htmlpage":"ENAS5092_2017032739",
"new_id":"16",
"new_nametree":"Rx.of localised and locally advanced disease",
"new_numtree":"4.3.6.0",
"new_htmlpage":"ENAS5092_2017032739"
},
{
"old_id":"17",
"old_nametree":"Management of advanced/ metastatic disease",
"old_numtree":"4.4.0.0",
"old_htmlpage":"null",
"new_id":"17",
"new_nametree":"Management of advanced/ metastatic disease",
"new_numtree":"4.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"18",
"old_nametree":"Overview",
"old_numtree":"4.4.1.0",
"old_htmlpage":"ENAS5092_4.3.1.0",
"new_id":"18",
"new_nametree":"Overview",
"new_numtree":"4.4.1.0",
"new_htmlpage":"ENAS5092_4.3.1.0"
},
{
"old_id":"19",
"old_nametree":"Treatment of CRPC",
"old_numtree":"4.4.2.0",
"old_htmlpage":"ENAS5092_4.3.2.0",
"new_id":"19",
"new_nametree":"Treatment of CRPC",
"new_numtree":"4.4.2.0",
"new_htmlpage":"ENAS5092_4.3.2.0"
},
{
"old_id":"20",
"old_nametree":"Treatment of metastatic disease",
"old_numtree":"4.4.3.0",
"old_htmlpage":"ENAS5092_2017032740",
"new_id":"20",
"new_nametree":"Treatment of metastatic disease",
"new_numtree":"4.4.3.0",
"new_htmlpage":"ENAS5092_2017032740"
},
{
"old_id":"21",
"old_nametree":"Palliative care",
"old_numtree":"4.5.0.0",
"old_htmlpage":"ENAS5092_4.4.0.0",
"new_id":"21",
"new_nametree":"Palliative care",
"new_numtree":"4.5.0.0",
"new_htmlpage":"ENAS5092_4.4.0.0"
},
{
"old_id":"22",
"old_nametree":"Personalised medicine",
"old_numtree":"5.0.0.0",
"old_htmlpage":"ENAS5092_5.0.0.0",
"new_id":"22",
"new_nametree":"Personalised medicine",
"new_numtree":"5.0.0.0",
"new_htmlpage":"ENAS5092_5.0.0.0"
},
{
"old_id":"23",
"old_nametree":"Follow-up and long term implications",
"old_numtree":"6.0.0.0",
"old_htmlpage":"ENAS5092_6.0.0.0",
"new_id":"23",
"new_nametree":"Follow-up and long term implications",
"new_numtree":"6.0.0.0",
"new_htmlpage":"ENAS5092_6.0.0.0"
},
{
"old_id":"24",
"old_nametree":"Summary of recommendations",
"old_numtree":"7.0.0.0",
"old_htmlpage":"null",
"new_id":"24",
"new_nametree":"Summary of recommendations",
"new_numtree":"7.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"25",
"old_nametree":"Diagnosis and pathology",
"old_numtree":"7.1.0.0",
"old_htmlpage":"ENAS5092_7.1.0.0",
"new_id":"25",
"new_nametree":"Diagnosis and pathology",
"new_numtree":"7.1.0.0",
"new_htmlpage":"ENAS5092_7.1.0.0"
},
{
"old_id":"26",
"old_nametree":"Staging and risk assessment",
"old_numtree":"7.2.0.0",
"old_htmlpage":"ENAS5092_7.2.0.0",
"new_id":"26",
"new_nametree":"Staging and risk assessment",
"new_numtree":"7.2.0.0",
"new_htmlpage":"ENAS5092_7.2.0.0"
},
{
"old_id":"27",
"old_nametree":"Treatment",
"old_numtree":"7.3.0.0",
"old_htmlpage":"null",
"new_id":"27",
"new_nametree":"Treatment",
"new_numtree":"7.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"28",
"old_nametree":"Management of local/ locoregional disease",
"old_numtree":"7.3.1.0",
"old_htmlpage":"null",
"new_id":"28",
"new_nametree":"Management of local/ locoregional disease",
"new_numtree":"7.3.1.0",
"new_htmlpage":"null"
},
{
"old_id":"29",
"old_nametree":"Overview",
"old_numtree":"7.3.1.1",
"old_htmlpage":"ENAS5092_7.3.1.1",
"new_id":"29",
"new_nametree":"Overview",
"new_numtree":"7.3.1.1",
"new_htmlpage":"ENAS5092_7.3.1.1"
},
{
"old_id":"30",
"old_nametree":"Hormone treatment",
"old_numtree":"7.3.1.2",
"old_htmlpage":"ENAS5092_7.3.1.2",
"new_id":"30",
"new_nametree":"Hormone treatment",
"new_numtree":"7.3.1.2",
"new_htmlpage":"ENAS5092_7.3.1.2"
},
{
"old_id":"31",
"old_nametree":"Post-operative radiotherapy",
"old_numtree":"7.3.1.3",
"old_htmlpage":"ENAS5092_7.3.1.3",
"new_id":"31",
"new_nametree":"Postoperative radiotherapy",
"new_numtree":"7.3.1.3",
"new_htmlpage":"ENAS5092_7.3.1.3"
},
{
"old_id":"32",
"old_nametree":"Treatment of relapse",
"old_numtree":"7.3.1.4",
"old_htmlpage":"ENAS5092_7.3.1.4",
"new_id":"32",
"new_nametree":"Treatment of relapse",
"new_numtree":"7.3.1.4",
"new_htmlpage":"ENAS5092_7.3.1.4"
},
{
"old_id":"33",
"old_nametree":"Management of advanced/ metastatic disease",
"old_numtree":"7.3.2.0",
"old_htmlpage":"null",
"new_id":"33",
"new_nametree":"Management of advanced/ metastatic disease",
"new_numtree":"7.3.2.0",
"new_htmlpage":"null"
},
{
"old_id":"34",
"old_nametree":"Overview",
"old_numtree":"7.3.2.1",
"old_htmlpage":"ENAS5092_7.3.2.1",
"new_id":"34",
"new_nametree":"Overview",
"new_numtree":"7.3.2.1",
"new_htmlpage":"ENAS5092_7.3.2.1"
},
{
"old_id":"35",
"old_nametree":"Treatment of CRPC",
"old_numtree":"7.3.2.2",
"old_htmlpage":"ENAS5092_7.3.2.2",
"new_id":"35",
"new_nametree":"Treatment of CRPC",
"new_numtree":"7.3.2.2",
"new_htmlpage":"ENAS5092_7.3.2.2"
},
{
"old_id":"36",
"old_nametree":"Palliative care",
"old_numtree":"7.3.3.0",
"old_htmlpage":"ENAS5092_7.3.3.0",
"new_id":"36",
"new_nametree":"Palliative care",
"new_numtree":"7.3.3.0",
"new_htmlpage":"ENAS5092_7.3.3.0"
},
{
"old_id":"37",
"old_nametree":"Personalised medicine",
"old_numtree":"7.4.0.0",
"old_htmlpage":"ENAS5092_7.4.0.0",
"new_id":"37",
"new_nametree":"Personalised medicine",
"new_numtree":"7.4.0.0",
"new_htmlpage":"ENAS5092_7.4.0.0"
},
{
"old_id":"38",
"old_nametree":"Follow-up and long term implications",
"old_numtree":"7.5.0.0",
"old_htmlpage":"ENAS5092_7.5.0.0",
"new_id":"38",
"new_nametree":"Follow-up and long term implications",
"new_numtree":"7.5.0.0",
"new_htmlpage":"ENAS5092_7.5.0.0"
},
{
"old_id":"39",
"old_nametree":"Glossary",
"old_numtree":"8.0.0.0",
"old_htmlpage":"ENAS5092_8.0.0.0",
"new_id":"39",
"new_nametree":"Glossary",
"new_numtree":"8.0.0.0",
"new_htmlpage":"ENAS5092_8.0.0.0"
}
]